Alzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant. In AD, the beta-amyloid precursor protein (β-APP) that ...
Jun 12, 2017
0
1
It has been 111 years since Auguste D. became the first person described with what is now called Alzheimer's disease. German psychiatrist Alois Alzheimer, for whom the disease is named, first publically reported his observations ...
Apr 12, 2017
2
13
Catch it early. Those are watchwords in the battle against a host of illnesses, from heart disease to cancer to Type 2 diabetes. Early detection gives physicians a chance to minimize damage, to insert a stent and keep blood ...
Apr 8, 2017
0
114
In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer's disease patients and mouse models of the disease, Johns Hopkins researchers say removing it prevents animals from ...
Mar 27, 2017
0
8
Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund – the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of beta-amyloid, the protein believed ...
Mar 13, 2017
0
1
New research from Lund University in Sweden has shown that intestinal bacteria can accelerate the development of Alzheimer's disease. According to the researchers behind the study, the results open up the door to new opportunities ...
Feb 10, 2017
0
4245
Biochemical reactions that cause Alzheimer's disease could begin in the womb or just after birth if the fetus or newborn does not get enough vitamin A, according to new research from the University of British Columbia.
Jan 27, 2017
0
157
Acetylcholine is a neurotransmitter in the brain that plays an important role in controlling attention and cognition. Acetylcholine system dysfunction is believed to be one of the causes of Alzheimer's disease (AD) and vascular ...
Jan 26, 2017
0
0
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent ...
Dec 19, 2016
0
3
(HealthDay)—Protein fragments that form plaques in the brains of Alzheimer's patients might also stiffen their heart muscle and increase their risk of heart failure, a new study reports.
Nov 28, 2016
0
870
